Objective Brucellosis remains as a widespread zoonosis, both worldwide and in our country that causes serious public health problems with the potential to create disease in humans and animals. The aim of the present study was to examine the characteristics of brucellosis patients followed in our clinic and to compare these cases with those reported in the literature. Methods Four hundred and forty-seven patients who were treated in our clinic between March 2004 and March 2011 for a diagnosis of brucellosis and who were followed for one year after the completion of treatment were retrospectively examined. Data for the patients were obtained using brucellosis follow-up forms. Results Of the 447 patients, 261 (58.4%) were women, and the mean age was 48±17 years. Focal organ involvement was detected in 178 (40%) cases, with the musculoskeletal system being the leading site (30.6%), followed by the central nervous system (5.4%). Spondylodiscitis exhibited a significant correlation with an advanced age, a high erythrocyte sedimentation rate (ESR) and the C-reactive protein (CRP) level on admission (p=0.001, p=0.0001 and p=0.001, respectively). A significant correlation was found between sacroiliitis and a younger age (p=0.003). Relapse was observed in 35 (7.8%) cases. Conclusion The present study allowed us to scrutinize the characteristics and complications of patients with brucellosis. Focal organ involvement of the musculoskeletal system was observed in the present cases, particularly spondylodiscitis and sacroiliitis. Spondylodiscitis was detected in elderly patients with high CRP and ESR values, whereas sacroiliitiswas seen in younger patients. We believe that age, symptom duration and laboratory parameters should be evaluated in patients with brucellosis and that older patients in particular should be precisely examined for bone and joint complications.
Introduction
Brucellosis is a zoonosis caused by Brucella spp. that can involve various tissues and systems in humans and leads to different clinical pictures. Although the incidence of brucellosis has shown a mild decrease in recent years, Turkey remains among the countries in which the disease is prevalent. According to data from the Ministry of Health of the Republic of Turkey, the number of brucellosis cases reported in 2010 was 7,703 (1) . Brucellosis is transmitted to humans by direct contact with infected animals or consumption of unpasteurized milk and milk products obtained from infected animals. A high fever, sweating and muscle and joint pain are the most common complaints. Brucellosis may present with various complications, with musculoskeletal system involvement being the leading symptom (2). Treating the disease, which progresses with complications and relapses, is difficult and requires a long amount of time.
The present study aimed to retrospectively scrutinize the clinical characteristics, laboratory findings, complications and treatment outcomes of brucellosis patients followed in our clinic and to compare these data with those reported in the literature.
Materials and Methods
This study comprised a total of 447 adult patients (age> 15 years) who were diagnosed with brucellosis at the Infectious Diseases Clinic of Baskent University Adana Training and Research Center between March 2004 and March 2011 and followed for one year after the completion of their treatment period. The files of the patients were retrospectively scrutinized. For each patient, demographic data, presenting complaints, system inquiry and physical examination findings, a complete blood count, the erythrocyte sedimentation rate (ESR), the C-reactive protein (CRP) level, hepatic function test results and the serum creatinine level at the time of diagnosis, Brucella standard tube agglutination (STA) test results, body temperature, time of decrease in body temperature, results of blood cultures, radiological imaging findings, therapy combinations, duration of and response to therapy and adverse drug events were recorded on brucellosis follow-up forms. Data from these forms were then transferred to the SPSS 17.0 (Statistical Package for the Social Sciences) statistics program.
The diagnosis of brucellosis was made based on positive Brucella STA test results (titer>160) in the presence of clinical signs and symptoms suggestive of brucellosis or a 4-fold increase in the serum antibody concentration in a serum sample obtained at two-to three-week intervals and/or isolation of Brucella spp. from the blood, bone marrow or any body fluid or tissue culture. The blood culture samples were incubated in the BACTEC 9050 and BACTEC 9240 systems (Becton-Dickinson, Maryland, ABD) for 21 days. Gramnegative coccobacilli grown in the blood culture or other body fluids were identified via conventional biochemical tests (motility, catalase, oxidase and glucose fermentation) (with the BACTEC 9240 system being used since 2006).
A diagnosis of musculoskeletal system complications was made based on whole-body bone scintigraphy (Technetium 99m) and/or findings obtained using appropriate radiological imaging methods in the presence of consistent physical examination findings.
A diagnosis of neurobrucellosis was made considering the presence of abnormal findings obtained from cerebrospinal fluid (CSF) analyses (>10 leukocyte/mm 3 , protein >45 mg/ dL, glucose <2/3 of the blood glucose level) and STA positivity of any titer in the CSF. Cranial CT and/or MRI were performed in necessary cases.
Genitourinary system involvement was diagnosed based on scrotal ultrasonography or transrectal ultrasonography in addition to physical examination findings in required cases.
The disease was divided into three groups according to the duration of presenting symptoms: shorter than two months was defined as acute, between two months and one year was defined as subacute and longer than one year was defined as chronic (3) . The patients were given two-drug or three-drug antibiotic combinations depending on their clinical signs and complications. The antibiotic therapy included doxycycline (200 mg/day), rifampicin (600 mg/day), ciprofloxacin (1,000 mg/day), streptomycin (one g/day, IM), co-trimoxazole 800/400 mg (two tablets a day) and ceftriaxone (4 g/day). The duration of therapy was adjusted according to the complications (spondylodiscitis, neurobrucellosis, infective endocarditis, etc.) as well as radiological and clinical improvements observed during control visits.
The patients received control visits in the 1st, 3rd and 6th months and the 1st year after the completion of treatment. The control analyses included Brucella STA tests, Brucella STA tests with rivanol and measurement of the complete blood count and the levels of CRP, ESR and hepatic enzymes. Blood cultures were obtained from patients who exhibited suspicious relapses during control visits. Patients with persistent signs and symptoms at the end of treatment were considered to be nonresponsive. Relapse was defined as recurrence of complaints and signs at any time within the first year after treatment together with elevated Brucella STA titers or Brucella STA tests with rivanol ! 1/160 and/or growth on a blood culture.
The SPSS 17.0 software package program was used for the statistical analysis of data. Categorical measurements were summarized as the number and percentage, whereas continuous measurements were summarized as the mean and standard deviation (median, minimum and maximum when required). Categorical variables were compared using Pearson's Chi-square test or Fisher's exact test. Distributions were controlled for the intergroup comparison of continuous variables; Student's t-test was used for normally distributed parameters according to the number of variables, whereas the Mann Whitney U-test was used for parameters that were not normally distributed. The statistical significance level was accepted as a 'p' value smaller than 0.05 for all tests.
Results
The characteristics of the 447 patients are presented in Table 1 .
The leading presenting complaints were weakness (85%), joint pain (81%), fever (74%) and sweating (73%). During clinical observation, subfebrile fevers were detected in 19 (4.3%) patients and high fevers were detected in 69 (15.4%) patients. Of these patients, 43 (9.6%) had hepatomegaly and 72 (16.1%) had splenomegaly. Focal organ involvement was present in 178 (40%) cases, with the musculoskeletal system (30.6%) being the leading site, followed by the central nervous system (5.4%), genitourinary system (3.1%) and cardiovascular system (0.7%). Spondylodiscitis (19%) was the most prevalent complication of musculoskeletal system involvement. Seventy-eight percent of the patients with spondylodiscitis exhibited lumbar region involvement (lumbar, thoracolumbar, lumbosacral and thoracolumbosacral). Paravertebral and/or epidural abscesses were observed in 19 (22%) of the patients with spondylodiscitis.
Standard tube agglutination tests were positive in 97.5% of the patients, whereas Brucella spp. was grown in the blood cultures of 162 of 377 patients. Based on the Pearson's chi-square test, there was a statistically significant correlation between blood culture positivity and the acute form of the disease (p=0.0001).
There was a statistically significant correlation between the subacute form of the disease and relapse (p=0.030). An evaluation of disease forms according to signs and symptoms is presented in Table 2 .
The relationships between the clinical picture and age, the ESR level and the CRP level are demonstrated in Table 3 .
Urinary system involvement was diagnosed in 14 patients with genitourinary system involvement due to epididymoorchitis in nine cases, prostatitis in three cases and growth of Brucella spp. in urine samples in two cases of nephrolithiasis without signs of epididymo-orchitis or prostatitis.
The treatment of each patient was specified considering current complications, side effects and drugs properties. The most commonly used therapy option was a six-week doxycycline+rifampicin combination, which was applied in 225 (50.3%) patients. Patients with spondylodiscitis were usually treated with streptomycin [1 g/day, intramuscular (IM)] in the first three weeks of treatment together with a doxycycline+rifampicin combination for six months. Patients with sacroiliitis and peripheral arthritis were treated with streptomycin (one g/day, IM for 21 days) and a doxycycline+ri-fampicin combination for six weeks. Twenty-two of the 24 neurobrucellosis patients received a doxycycline+rifampicin combination together with ceftriaxone [4 g/day, intravenous (IV)] for the first month, which was continued for a total of six months.The remaining two patients received a cotrimoxazole+doxycycline+rifampicin combination for six months. Three patients with infective endocarditis received a doxycycline+rifampicin combination together with ceftriaxone (4 g/day, IV) for the first month, then the involved cardiac leaflet was changed with surgical intervention and the treatment was continued for a total of one year. Some of the patients underwent drug substitution due to adverse drug events. Twenty-five (5.8%) of the patients developed drugrelated adverse events, with gastrointestinal intolerance being the leading symptom, involving 16 cases. This effect mostly resulted from doxycycline use, and the drug was excluded from the treatment protocol in such patients. Streptomycin was also removed from the treatment protocol in two cases due to ototoxicity. Four patients developed hepatic enzyme elevation due to rifampicin,which was discontinued in three cases. The treatment was also changed in a patient with photosensitivity due to doxycycline and in two patients with rashes caused by rifampicin.
Relapse was diagnosed in 35 (7.8%) patients and occurred as a result of spondylodiscitis in four of these cases. No statistically significant relationships were found between relapse and treatment (p=0.580).
Discussion
Brucellosis is one of the most common zoonoses worldwide and remains endemic in Turkey. Whereas the primary contamination pathway is the consumption of unpasteurized dairy productsin developing countries, the disease is more frequently transmitted by occupational exposure in developed countries (3, 4) . Some epidemiological studies conducted in Turkey have demonstrated that 62.6-94.6% of affected patients have a history of consuming unpasteurized dairy products (2, 5-10). Consistent with the literature, the present study showed that 81% patients have a history of unpasteurized dairy product consumption. This suggests that brucellosis occurs as a result of failing to eradicate the disease from animals due to problems that result from immunization programs carried out in Turkey, as well asthe continued consumption of unpasteurized dairy products, even in urban areas. Therefore, we believe that necessary precautions should be taken to prevent consumption of such products.
Certain occupational groups, including animal breeders, veterinarians, healthcare staff, laboratory workers, slaughterhouse employees and meat industry employees, are at risk of contracting brucellosis (10) . Twenty percent of the present patients were animal breeders, and occupational risks were identified in 12 cases (one laboratory worker, seven veterinarians, two butchers, two slaughterhouse employees).
Brucellosis is a systemic infectious disease that can lead to various clinical pictures; therefore, the signs and symptoms are usually not specific to the disease. Joint pain, a high fever, weakness, sweating and low back pain are the most common symptoms (10) . Whereas fever is present as a complaint in 74% of cases, it is detected as a sign in only (10) (11) (12) (13) (14) (15) . The higher rates observed in the present study might have resulted from the fact that the diagnoses of splenomegaly and hepatomegaly were made based on not only physical examinations, but also ultrasonography. The disease appears in three forms according to the symptom duration: acute, chronic and subacute. In various studies, the acute form is reported to beobserved in 25-77% of cases, the subacute form is reported to be observed in 12.5-59% of cases and the chronic form is reported to be observed in 5-27.5% of cases (16) . These differences are attributed to economic and cultural differences among patients, as well as differences in diagnostic approaches. In the present study, 68% of patients had the acute form of the disease, 22.6% had the subacute form and 9.4% had the chronic form. Another study from Turkey identified a significant correlation between fever and the acute form of the disease (16) . Brucellosis may progress with complications that involve many tissues and organs.The prevalence of focal involvement has been reported to range between 27.7% and 43.2% in many studies (10) . In the present study, 40% of the patients exhibited focal involvement. Although musculoskeletal complications are the leading complications of brucellosis, various prevalence rates have been reported in studies. In the present study, musculoskeletal involvement was the leading complication, with a prevalence rate of 30.6%. Although some researchers have reported sacroiliitis to be the most prevalent complication, spondylodiscitis was the leading complication in the present study, as well as in other studies (2). Consistent with the literature (2, [16] [17] [18] , in the present study, spondylodiscitis was detected in the old age group, while sacroiliitis was detected in the young age group. Differences between studies regarding the frequency of the location of musculoskeletal involvement can be attributed to whether radiological or scintigraphic imaging methods are used for diagnosis, differences between the sensitivities of the methods and differences in the age and gender distributions of the patient groups.
Consistent with the literature, the lumbar region was the most common site of spondylodiscitis in the present study. Paravertebral and/or epidural abscesses are seen in spondylodiscitis cases. In the present study, paravertebral and/or epidural abscesses together with spondylodiscitis were detected in 22% of cases. A high ESR level remains an important laboratory parameter that indicates focal involvement. Colmenero et al. observed high ESR levels in patients who developed complications (14) . Ta"ova et al. (6), Geyik et al. (19) , Hashemi et al. (20) and Turan et al. (17) found high ESR levels in 31%, 42%, 38.5% and 70.2%, respectively, of patients with brucellosis-related bone-joint involvement. Similar to the study conducted by Kurtaran et al. (16) , the present found statistically significant correlations between spondylodiscitis and the ESR and CRP levels. The presence of significantly high ESR and/or CRP levels in complicated cases suggests that these parameters can be helpful for diagnosing complicated cases.
Neurobrucellosis is a rare complication of brucellosis that usually presents with the clinical picture of meningitis and meningoencephalitis (16) . Various studies have reported its prevalence to range between 1.7% and 17.8% (11, 14, 21, 22) . This rate was found to be 5.4% in the present study. The neurological pictures of neurobrucellosis are quite different and may occur in the form of meningitis, encephalitis, myelitis-radiculoneuritis, demyelination, brain abscesses, epidural abscesses, granulomas or meningovascular syndromes. Meningitis (four acute, 16 subacute/ chronic) was the most common clinical picture, involving 83% of the present cases. Three patients had encephalomyelitis (meningoencephalomyelitis, transverse myelitis and cerebellar abscesses) and one patient had polyradiculoneuritis (Miller Fisher's Syndrome). The mortality of neurobrucellosis ranges between 0% and 5.5% depending on the use of appropriate antibiotics (23) . Despite exhibiting a good prognosis, affected patients may develop permanent neurological sequelaeas well. Three of 24 patients healed with permanent neurological sequelae (paraparesis, loss of hearing, dementia and sphincter dysfunction), whereas 21 patients achieved a complete recovery.
Urogenital system involvement is encountered in 2-10% of male cases with brucellosis and primarily clinically presents with unilateral epididymo-orchitis (3, 4) . In the present study, genitourinary system involvement was the third leading complication, with a prevalence rate of 3.1%. However, this rate reached up to 7.5% when only male patients were taken into consideration and became the second leading complication in men after musculoskeletal system involvement. Of the present patients, nine had epididymo-orchitis (three bilateral and six unilateral). Consonant with the literature, unilateral epididymo-orchitis was most frequently observed in the present cases.
Brucella spp. was grown in the urine cultures of the patients with urinary tract infections. Therefore, we believe that the presence of Brucella spp. should also be considered when evaluating urine cultures in endemic regions.
Brucellosis-related endocarditis is the most common form of cardiovascular involvement and is seen in less than 2% of patients. Buzgan et al. (10) conducted a study comprising 1,028 patients and reported endocarditis in 0.7% of the cases. Akdeniz et al. (12) reported endocarditis in 1% of cases, while Kokoglu et al. (13) reported endocarditis in 1.5% of cases. The prevalence of endocarditis observed in the present study is consistent with that reported in the literature.
A definitive diagnosis of brucellosis is made based on isolation of the agent from the blood, bone marrow or other tissue. The rate of culture positivity in patients with brucellosis is reported to be 68.8% by Colmenero et al. (14) (10) . As seen in the study conducted by Buzgan et al., blood culture positivity is most frequently observed in acute cases. Different combinations of antibiotics can be used to treat brucellosis. The World Health Organization recommends doxycycline at a dose of 200 mg/day and rifampicin at a dose of 600-900 mg/day for six weeks or six weeks of doxycycline or tetracycline and three weeks of streptomycin. In the present study, the most frequently used therapy option was six weeks of a doxycycline+rifampicin combination. Relapse was detected in 35 (7.8%) cases. Relapse was more prevalent in the patient (15%) who received ciprofloxacin and rifampicin for 30 days. Since the present study was not designed to compare treatment regimens, the groups were not homogeneous. Therefore, the analyses failed to identify any correlations between treatment regimens and relapse.
In conclusion, providing a diagnosis, identification of complications, treatment and follow-up is quite important in patients with brucellosis, which has a high prevalence rate and remains endemic in Turkey despite the fact that it is a preventable disease and prevention efforts are ongoing. Patient age, symptom duration and laboratory results can help the clinician to identify the complications of this disease, which progresses with serious complications and results in a loss of economic labor. Older patients should be cautiously investigated, particularly for bone and joint involvement. In order to prevent this disease, which damages the national economy by affecting both the animal industry and human health, veterinary studies should be performed and necessary precautions should be taken to prevent the use of unpasteurized milk and dairy products.
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